Invitrogen Corporation has announced that it has introduced its NCode™ microRNA Microarray platform. Invitrogen claims that, the NCode™ miRNA profiling platform enables sensitive profiling of miRNAs ...
DUBLIN, Aug. 28, 2023 /PRNewswire/ -- The "MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets" report has been added to ResearchAndMarkets.com's offering. The miRNA tools market has ...
cFDNA characteristics in transitional cell carcinoma (TCC) patients who achieved complete response to checkpoint inhibitors (CPI). Table 1. DEmiRs able to cluster accordingly with metastatic status ...
A paper in PNAS this week reporting that a signature of microRNA (miRNA) gene expression correlates with diagnosis and prognosis of B-cell chronic lymphocytic leukemias (CLLs) has drawn skepticism ...
Potential of Field Is Catalyst for Emerging Diagnostic and Therapeutic Strategies As key regulators of gene expression and cellular machinery, microRNAs may be the most significant discovery in ...
The enormous potential of miRNAs is driving new technologies for research, diagnostic, and therapeutic applications. miRNAs, a class of small noncoding RNAs of 19–30 nucleotides in length, regulate ...
Show More From the Departments of Molecular Virology, Immunology and Medical Genetics and Comprehensive Cancer Center, Ohio State University, Columbus, OH; Departments of Pathology and Surgical and ...
Feb. 1, 2011, 8:45 AM UTC / Source: GlobeNewswire COPENHAGEN, Denmark, Feb. 1, 2011 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ) today announced the launch of its 2011 global research grant program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback